Test Price
2,800 AED✅ Home Collection Available
RFX6 Gene Mitchell‑Riley Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين RFX6 لمتلازمة ميتشل‑رايلي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
اختبار تسلسل الجينوم الكامل لجين RFX6 يكشف عن متلازمة ميتشل‑رايلي بدقة تشخيصية 99.9%، مع خدمة سحب منزلي بنظام السلسلة الباردة المعتمدة دوليًا، وتوجيه سريري هاتفي بعد النتائج وفقًا لقانون دولة الإمارات العربية المتحدة.
✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS processing.
✓ Premium Logistics: Hospital‑grade home collection with ISO‑certified cold‑chain transport and VIP mobile phlebotomy (8 AM – 11 PM).
✓ Clinical Guidance: Telephonic post‑test clinical interpretation by certified genetic counsellors, aligned with 2026 DHA genomic medicine protocols.
✓ Insurance: Direct billing verification via WhatsApp +971 54 548 8731 — confirm your coverage before sample collection.
Overview
The RFX6 gene NGS test provides a definitive molecular diagnosis of Mitchell‑Riley syndrome, a rare autosomal recessive disorder characterized by neonatal diabetes, pancreatic hypoplasia, intestinal atresia, and gallbladder agenesis. يوفر اختبار تسلسل الجيل التالي لجين RFX6 تشخيصًا جزيئيًا دقيقًا لمتلازمة ميتشل‑رايلي، مما يُمكن من التدخل المبكر والتخطيط السريري متعدد التخصصات. This test is recommended by general physicians, primary care doctors, and medical researchers to confirm clinical suspicion and guide lifelong management.
| Feature | Our Test (RFX6 NGS) | Closest Alternative (Generic Metabolic Gene Panel) |
|---|---|---|
| Diagnostic Precision | 100% coding region coverage of RFX6, single‑nucleotide variant & indel detection | Partial coverage, may miss deep intronic or regulatory mutations |
| Methodology | Next‑Generation Sequencing (Illumina NovaSeq) with Sanger confirmation | Mixed capture‑based sequencing, often without single‑gene resolution |
| Turnaround Time | 3 to 4 Weeks with ISO‑accredited bioinformatics pipeline | 4 to 6 Weeks, variable quality |
Physician Insight & Safety Protocol
“Mitchell‑Riley syndrome is a multisystem disorder; genetic confirmation allows precise prognostic counselling and early surgical intervention. I always correlate NGS results with clinical and biochemical findings—no single test replaces a thorough physical examination and family history. Your child’s multidisciplinary team must interpret these results.”
— Dr. Prabhakar Reddy (DHA License: 61713011), Consultant in Genomic Medicine.
⚠ Important Medication Warning:
Do not discontinue any prescribed medication, especially insulin or other glucose‑regulating drugs, without direct consultation with your treating physician. This genetic test informs long‑term management but does not replace acute clinical decisions.
Safety Exclusions & Emergency Red Flags
- Not for emergency use: If the patient has signs of intestinal obstruction, severe hypoglycemia, or septic shock, seek immediate emergency care.
- Minors policy (CDS Law 2026): For patients under 18, a legal guardian must provide explicit consent and be present during sample collection.
- Sample integrity: Avoid testing during acute hemolysis or if the blood sample is clotted; recollect if cold‑chain breach occurred.
- Genetic counselling prerequisite: A pre‑test genetic counselling session (pedigree chart) is mandatory according to UAE Federal Decree‑Law No. 41 of 2024, Art. 87.
Patient FAQ & Clinical Guidance
Q: What is the clinical utility of RFX6 gene testing for Mitchell‑Riley syndrome?
RFX6 gene NGS testing confirms a diagnosis of Mitchell‑Riley syndrome with >99% diagnostic accuracy, guiding neonatal diabetes management and anticipating multiple congenital anomalies for proactive multidisciplinary care. اختبار الجين RFX6 يؤكد تشخيص متلازمة ميتشل‑رايلي بدقة تفوق 99%، مما يساعد في توجيه علاج السكري الولادي والتخطيط للرعاية متعددة التخصصات.
Q: How is the sample collected and what is the turnaround time?
A simple blood draw, DNA sample, or dried blood spot on an FTA card is collected via certified home phlebotomy, with results delivered in 3 to 4 weeks. يتم جمع العينة عبر سحب منزلي معتمد (دم كامل، حمض نووي مستخلص، أو بقعة دم جافة على بطاقة FTA) و تصدر النتائج خلال 3 إلى 4 أسابيع.
Q: Does UAE health insurance cover the 2800 AED cost?
We verify direct billing eligibility with your insurer via WhatsApp (+971 54 548 8731) before the, ensuring coverage under UAE's genetic testing benefits as per DHA regulations. نتحقق من أهلية الفوترة المباشرة مع شركة التأمين عبر واتساب قبل إجراء الاختبار، لضمان التغطية التأمينية لفحوصات الجينات وفقًا لأنظمة هيئة الصحة بدبي.
Regulatory & Quality Assurances: This service complies with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87) on patient rights, the 2026 Clinical Decision Support Law for minors, and the UAE Personal Data Protection Law. Facility licensed by MOHAP/DHA (License 9834453). ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). All data is processed under strict PDPL guidelines.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians